期刊文献+

HPLC法测定他克莫司软膏剂含量及含量均匀度 被引量:16

Content determination and content uniformity of tacrolimus ointment by HPLC
下载PDF
导出
摘要 目的建立他克莫司软膏剂含量测定方法。方法用四氢呋喃∶水∶无水乙醇(5∶2∶1)先、后在60℃水浴和冰浴中提取软膏,应用反相高效液相色谱法测定了两种规格共6批(30g,每支0.03%;30g,每支0.1%)他克莫司软膏剂的含量及含量均匀度。色谱条件:TSKgelODS-80TM柱(150mm×4.6mm,5μm);柱温(55±1)℃,流动相为水∶异丙醇∶四氢呋喃(5∶2∶2),流速0.6ml/min;紫外检测器,检测波长220nm。结果他克莫司的色谱峰与其它杂质峰能够较好的分离,柱理论塔板数按他克莫司峰计为5000,规格为30g,每支0.03%软膏的80%加样平均回收率为100.6%(RSD=0.5%,n=3),100%加样平均回收率为100.2%(RSD=1.6%,n=3),120%平均回收率为98.7%(RSD=2.3%,n=3);规格为30g,每支0.1%软膏的80%加样平均回收率为99.3%(RSD=0.5%,n=3),100%加标平均回收率为100.8%(RSD=1.6%,n=3),120%加标平均回收率为99.3%(RSD=0.7%,n=3);0.03%规格软膏的线性方程为y=6989786x+105.4(r=0.9999),浓度范围0.0075~0.0225mg/ml;0.1%规格的线性方程为y=6995488x-64.2(r=0.9999),浓度范围0.025~0.075mg/ml。他克莫司的检测限为0.002mg/ml,定量限为0.006mg/ml。结论方法简便,快速,回收率高,重现性好,可用于他克莫司软膏剂(0.03%,0.1%)含量测定,能够对药品质量进行控制。 Objective The content determination of tacrolimus ointment and its content uniformity were studied by using reversed-phase high performance liquid chromatography. Methods In this paper, for quantitative analyses of tacrolimus ointment (two strengths, 30g: 0.1%/tube and 30g: 0.03%/tube), a mixture of THF, water and absolute ethanol (5 : 2 : 1) in water bath (60℃) and followed by ice bath was used to extract the ointment to prepare the sample solution. The separation was carried out on a TSK gel ODS-80^TM (150mm×4.6mm, 5μm) with PDA detector at 220nm, the temperature of column was 55℃. The mobile phase consisted of water : isopropanol : THF (5 : 2 : 2), at a flow rate of 0.6ml/min. Result Good resolution was achieved between the peak of tacrolimus and the relative impurities. The 80%, 100% and 120% sample added recoveries for one strength (30g: 0.03%/tube) were 100. 6%, 100.2% and 98.7% respectively, and for another strength (30g: 0.1%/tube) were 99.3%, 100.8% and 99.3% respectively. Conclusion This HPLC method for content determination of tacrolimus ointmentis was simple, rapid, reproducible, and with high recovery. It was also feasible to assay and determinate the content uniformity of tacrolimus ointment (0.03% and 0.1%).
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2005年第12期748-751,755,共5页 Chinese Journal of Antibiotics
关键词 他克莫司 软膏 含量测定 高效液相色谱法 Tacrolimus Ointment Content determination HPLC
  • 相关文献

参考文献10

  • 1Kino T,Hatanaka H,Hasbimoto H,et al.FK506,a novel immunosuppressant isolated from a Streptomyces I.Fermentation,isolation,and physico-chemical and biological characteristic [J].J Antibiot,1987,40(9):1249.
  • 2Goto T,Kino T,Hatanaka H,et al.FK506:historical perspectives [J].Transplant Proc,1991,23(6) :2731.
  • 3Tanaka H,Kuroda A,Marusawa H,et al.Physicochemical properties of FK506,a novel immunosuppressant isolated from Streptomyces tsukbaensis [J].Transplant Proc,1987,4(5,Suppl 6):11.
  • 4Harding M W,Galat A,Uehling D E,et al.A receptor for the immunosuppressant FK506 is a cistrans peptidylproly isomerase [J].Nature,1989,341:758.
  • 5Siekierka J J,Staruch M J,Hung S H Y,et al.FK506,a potent novel immunosuppressive agent,binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein,cyclophilin [J].J Immunol,1989,143 (5):1580.
  • 6Gjertson D W,Ceeks J M,Terasaki P I.The relative effects of FK506 and cyclosperine on short- and long-term kidney graft survival [J].Transplantation,1995,27:60.
  • 7Shapiro R,Jordan M,Scantlebury V,et al.FK506 in clinical kidney transplantation [J].Trangplant Proc,1991,23(6) :3065.
  • 8Jordan M L,Shapiro R,Vivas C A,et al.FKS06 rescue for resistant renal allografts under primary cyclosporine immunosuppression [J].Transplantation,1994,57:860.
  • 9International conference on harmonization of technical requirements for registration of pharmaceuticals for human use (ICH) Q2a,Q2b [C].2000.
  • 10Akashi T,Nefuji T,Yoshida M,et al.Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography [J].J Pharm Biomed Anal,1996,14:339.

同被引文献128

引证文献16

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部